醫思醫療(02138.HK)增持全港痛症治療中心股權至75%
醫思醫療(02138.HK)公布,以總代價9,460萬元,增持Hong Kong Pain and Wellness Solution Limited合共24%股權,總代價將透過配發及發行醫思醫療股價支付。
根據買賣協議,朱君璞脊骨神經科醫生及林福傑脊骨神經科醫生將悉售所持目標公司股權。醫思醫療將透過配發及發行2,252.4萬股代價股份及發行1,000萬份認股權證支付。朱及林於緊隨發行及配發代價股份後,將分別持有醫思醫療2.25%及0.11%股權。發行價為每股代價股份4.2元,較股份於7月17日之收市價每股4.03港元,溢價4.2%。
交易完成後,醫思醫療將持有目標公司75%股權,而目標集團之財務資料將繼續於集團之綜合財務報表綜合入賬。兩位賣方各自提供溢利保證,於未來五年(即截至2025年3月31日止)內保證目標公司附屬公司的累計淨溢利總額不得少於1.88億元。兩位賣方除繼續為集團管理及營運整合及拓展亞太區痛症業務外,更會參與管理集團醫療科目的整合。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.